Evolve to commence trading on the CSE on December 17, 2025 under the ticker symbol “EVR” Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — Evolve Royalties Ltd. (CSE: EVR) (“Evolve” or the “Company”) (formerly Voyageur Minerals Explorers Corp.) is pleased to announce that it has completed its previously-announced business combination (the “Business Combination”) with Evolve Strategic Element Royalties Ltd. and its listing on the Canadian Securities Exchange (“CSE”). Evolve’s common shares (the “Evolve Shares”) are expected to commence trading on the CSE on December 17, 2025 under the symbol “EVR”. The Company’s listing statement is available on its...

Advini and Cordier by InVivo Announce Their Entry into Exclusive Negotiations to Strengthen Their Position in the French Wine Industry Advini Group and Cordier by InVivo announce entry into exclusive negotiations to merge certain activities This merger, sought by both groups, fits perfectly into a strategy of brand, product range, and sales network complementarity. It would allow Advini to strengthen its position in the Bordeaux region with the Cordier brand and enter the sparkling wine market with Café de Paris. Additionally, Advini’s export activities would be enhanced through Cordier’s distribution subsidiaries and presence, in the Netherlands, Belgium, the United States, Canada, South Africa, and Japan. AdVini would benefit from a wider and more diversified portfolio of prestigious brands, as well as a stronger distribution...

DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry”) today announced that, at its Special Meeting of Stockholders held earlier today, Berry stockholders voted to approve its combination with California Resources Corporation (“CRC”) (NYSE: CRC). As previously announced, under the terms of the merger agreement, Berry stockholders will receive a fixed exchange ratio of 0.0718 shares of CRC common stock for each share of Berry common stock. According to preliminary results, Berry stockholders approved the transaction with approximately 73% of the total shares outstanding and approximately 98% of the shares voted in support of the combination. The final voting results of Berry’s Special Meeting will be reported in a Form 8-K to be filed with the U.S. Securities and Exchange Commission (the “SEC”). The...

PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. About Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 100 countries. Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program...